DaVita, Inc. is one of the largest kidney care companies in the United States, with corporate headquarters in Denver, Colorado. Their offerings include in-center hemodialysis, peritoneal dialysis, home hemodialysis, vascular access management, chronic kidney disease education, and renal diet assistance.
Campaign Finance$4,542,435 Given
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of DaVita Inc
Names of Lobbyists
Firm Hired Amount DaVita Inc $25,105,000
Most Frequently Disclosed Lobbying Issues
- Medicare & Medicaid,
- Health Issues,
- Veterans Affairs,
- Fed Budget & Appropriations,
- Government Issues,
- Medical Research & Clin Labs,
Most Frequently Disclosed Bills
Bill No. Title H.R.3200 America's Affordable Health Choices Act of 2009 H.R.1 American Recovery and Reinvestment Act of 2009 S.CON.RES.13 S.691 Kidney Care Quality and Education Act of 2007 S.1796 America's Healthy Future Act of 2009 S.1776 Medicare Physician Fairness Act of 2009 S.1679 Affordable Health Choices Act H.R.3162 Children's Health and Medicare Protection Act of 2007 H.R.1193 Kidney Care Quality and Education Act of 2007 H.R.3590 Service Members Home Ownership Tax Act of 2009
RegulationsMentioned in 38 dockets; Submitted to 5 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "DaVita Inc" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for DaVita Inc
- Toggle 23 FDA Food Labeling: Revision of Reference Values and Mandatory Nutrients; Extension of Comment Period 2008
- Toggle 1 FDA Food Labeling: Revision of Reference Values and Mandatory Nutrients 2007
- Toggle 1 NLRB Proposed rule amending representation-case procedures 2011
- Toggle 1 HHS Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the Health Information Technology for Economic and Clinical Health Act; Proposed Rule 2010
- Toggle 1 HHS Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology 2010
Mentions in Document Text
View all mentions data for DaVita Inc
- Toggle 12 FDA Food Labeling: Revision of Reference Values and Mandatory Nutrients; Extension of Comment Period 2008
- Toggle 7 CMS Proposed Changes to the ASC Payment System and CY 2008 Payment Rates (PART OF CMS-1506-P) 2010
- Toggle 6 CMS Medicare Program; Accountable Care Organizations and the Medicare Shared Saving Program 2010
- Toggle 3 CMS Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 2010
- Toggle 3 CMS End Stage Renal Disease (ESRD) Conditions for Coverage 2010
- Toggle 2 CMS Medicare Program; Changes to the End-Stage Renal Disease Prospective Payment System for CY 2012, End-Stage Renal Disease Quality Incentive Program for PY 2013 and PY 2014; Ambulance Fee Schedule; and Durable Medical Equipment 2011
- Toggle 2 CMS Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P) 2012
- Toggle 2 CMS Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction 2011
- Toggle 2 CMS Exchanges Part II--Standards Related to Essential Health Benefits; Health Insurance Issuer and Exchange Responsibilities with Respect to Actuarial Value, Quality, and Accreditation CMS-9980-P 2012
- Toggle 2 CMS Revisions to Payment Policies and Five-Year Review of Relative Value Units Under the Physician Fee Schedule for CY 2007 and Other Changes to Payment Under Part B; Revisions to Ambulance Fee Schedule; Ambulatory Inflation Factor Update for CY 2007 2010